Senseonics Holdings, Inc. (SENS)
NYSEAMERICAN: SENS · Real-Time Price · USD
7.21
-0.04 (-0.55%)
At close: Oct 30, 2025, 4:00 PM EDT
7.32
+0.11 (1.53%)
After-hours: Oct 30, 2025, 7:33 PM EDT
Senseonics Holdings Revenue
Senseonics Holdings had revenue of $6.65M in the quarter ending June 30, 2025, with 36.67% growth. This brings the company's revenue in the last twelve months to $25.47M, up 5.94% year-over-year. In the year 2024, Senseonics Holdings had annual revenue of $22.47M with 0.37% growth.
Revenue (ttm)
$25.47M
Revenue Growth
+5.94%
P/S Ratio
9.98
Revenue / Employee
$217,658
Employees
117
Market Cap
293.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.47M | 82.00K | 0.37% |
| Dec 31, 2023 | 22.39M | 6.00M | 36.62% |
| Dec 31, 2022 | 16.39M | 2.71M | 19.85% |
| Dec 31, 2021 | 13.68M | 8.73M | 176.32% |
| Dec 31, 2020 | 4.95M | -16.35M | -76.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SENS News
- 8 days ago - Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time - GlobeNewsWire
- 24 days ago - Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update - GlobeNewsWire
- 2 months ago - Senseonics Holdings, Inc. (SENS) Eversense 365 Commercial Update Call (Transcript) - Seeking Alpha
- 2 months ago - Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics - Business Wire
- 2 months ago - Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365 - GlobeNewsWire
- 3 months ago - Senseonics Holdings, Inc. (SENS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Senseonics Holdings, Inc. Reports Second Quarter Financial Results - GlobeNewsWire
- 3 months ago - Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time - GlobeNewsWire